Pulmonology focuses on diagnosing and treating lung and airway conditions such as asthma, COPD, and pneumonia, as well as overall respiratory health.
COPD diagnosis begins with symptoms, exposure history, and objective lung testing. Breathlessness, chronic cough, mucus, wheezing, or fatigue may suggest COPD, but symptoms alone are not enough.
The doctor needs to confirm whether airflow limitation is present and whether it remains after bronchodilator testing.
Patients who want to review early warning signs can visit the COPD Disease Symptoms and Risk Factors section.
At Liv Hospital, pulmonology specialists evaluate clinical history, spirometry results, imaging findings, oxygen level, flare-up history, and daily activity limits together.

Spirometry: The Gold Standard
Spirometry is the key test used to measure airflow obstruction. It shows how much air a patient can breathe out and how quickly the air leaves the lungs.
During the test, the patient takes a deep breath and blows forcefully into a mouthpiece.
Spirometry may assess:
- FEV1
- FVC
- FEV1/FVC ratio
- Airflow limitation
- Disease severity
- Bronchodilator response
- Change compared with previous tests
- Possible asthma-COPD overlap
A post-bronchodilator FEV1/FVC ratio below the diagnostic threshold can support COPD diagnosis.
For a clearer explanation of how COPD limits airflow, patients can visit the COPD Disease Overview and Definition section.
Bronchodilator Reversibility Testing
Bronchodilator testing helps doctors understand how much airflow improves after inhaled medication.
The patient usually performs spirometry before and after receiving a short-acting bronchodilator.
This test may help assess:
- Fixed airflow obstruction
- Partial reversibility
- Asthma-like features
- Asthma-COPD overlap
- Treatment direction
- Inhaler response pattern
In asthma, airflow may improve more clearly after bronchodilator use. In COPD, obstruction often remains more persistent.
The distinction is important because treatment planning may change when asthma features are present.

Radiological Imaging
Imaging does not replace spirometry, but it can show lung structure and help rule out other causes of symptoms.
A chest X-ray may be used as a first step. It can show hyperinflation, flattened diaphragm, infection signs, or other visible abnormalities.
Chest CT may provide more detail when needed.
Imaging may help evaluate:
- Emphysema
- Air trapping
- Airway wall thickening
- Bronchiectasis
- Pneumonia
- Lung nodules
- Heart enlargement
- Cancer risk in selected high-risk patients
CT can also help identify which lung changes are more dominant, such as emphysema or airway disease.
Patients who want to learn how test results guide care can visit the COPD Disease Treatment and Management section.
Arterial Blood Gas Analysis
Arterial blood gas analysis may be needed in patients with severe COPD, low oxygen saturation, or suspected respiratory failure.
This test measures oxygen, carbon dioxide, and blood acidity.
ABG may help evaluate:
- Hypoxemia
- Carbon dioxide retention
- Acid-base balance
- Acute respiratory failure
- Chronic ventilatory problems
- Need for oxygen support
- Need for non-invasive ventilation
- Safety before major procedures
Not every COPD patient needs this test. It is usually selected when oxygen level, symptoms, or disease severity require closer assessment.
At Liv Hospital, ABG results are interpreted with spirometry, oxygen saturation, symptoms, and overall clinical status.

Alpha-1 Antitrypsin Screening
Alpha-1 antitrypsin deficiency is a genetic condition that can increase COPD risk. It may cause earlier or more severe emphysema, especially in smokers.
Screening may be considered when COPD appears at a younger age, progresses unexpectedly, or occurs without a clear smoking history.
Testing may include:
- Blood level measurement
- Genetic confirmation when needed
- Family risk discussion
- Liver health review in selected patients
- Long-term follow-up planning
Identifying this condition can change management and help family members understand whether they should seek medical advice.
At Liv Hospital, genetic risk is considered when the clinical pattern suggests it.
Assessment of Symptoms and Exacerbation Risk
COPD evaluation is not only about lung numbers. The doctor also needs to understand how symptoms affect daily life.
Assessment may include:
- Breathlessness level
- Cough burden
- Sputum pattern
- Sleep quality
- Energy level
- Activity limitation
- Rescue medication use
- Number of flare-ups in the past year
Tools such as dyspnea scales and symptom questionnaires may help describe disease impact more clearly.
Frequent exacerbations are important because they can predict future risk and influence treatment planning.
Patients who want to understand prevention after diagnosis can visit the COPD Disease Recovery and Prevention section.

Evaluation of Comorbidities
COPD can exist with other health conditions. These problems may worsen breathlessness, fatigue, sleep, or exercise capacity.
The doctor may evaluate for:
- Heart disease
- Pulmonary hypertension
- Sleep apnea
- Osteoporosis
- Anxiety
- Depression
- Diabetes
- Reflux-related cough
- Lung cancer risk in selected patients
Some patients may need ECG, echocardiography, sleep study, bone density scan, blood tests, or specialist consultation.
At Liv Hospital, COPD evaluation considers the full patient profile, not only the respiratory complaint.
Exercise Capacity Testing
Resting tests do not always show how COPD affects real life. Some patients feel acceptable while sitting but become breathless during walking or stairs.
Exercise assessment may include:
- Six-minute walk test
- Walking distance measurement
- Oxygen monitoring during activity
- Breathlessness scoring
- Heart rate response
- Desaturation check
- Rehabilitation baseline
- Oxygen need during movement
These tests help doctors understand functional capacity and plan pulmonary rehabilitation more accurately.
They can also show whether oxygen levels drop during activity even when resting oxygen seems stable.

Why Choose Liv Hospital for COPD Diagnosis?
COPD diagnosis should be structured, objective, and personalized. Liv Hospital supports patients with pulmonology expertise, spirometry, bronchodilator testing, imaging, oxygen assessment, ABG when needed, genetic screening, symptom scoring, and comorbidity evaluation.
For international patients, Liv Hospital can assist with appointment planning, communication support, diagnostic coordination, second opinion review, treatment planning, and follow-up guidance.
If breathlessness, chronic cough, mucus, wheezing, or repeated flare-ups affect daily life, Liv Hospital Pulmonology Department can help guide the next step.
Take the Next Step with Liv Hospital
COPD should be evaluated with the right tests before symptoms become harder to manage.
Contact Liv Hospital to discuss your symptoms, review previous lung tests, understand your diagnosis, and receive personalized guidance from pulmonology specialists.

Frequently Asked Questions
How is COPD diagnosed?
COPD is diagnosed through symptom review, exposure history, physical examination, and spirometry. Imaging, oxygen checks, blood gas testing, or genetic screening may be added when needed.
Why is spirometry important for COPD?
Spirometry measures airflow obstruction. It helps confirm whether the lungs empty air more slowly than expected and supports COPD severity assessment.
Do I need a CT scan for COPD diagnosis?
Not every patient needs CT. It may be used when emphysema, bronchiectasis, lung nodules, pneumonia, or another structural lung problem needs clearer evaluation.
What does bronchodilator testing show?
Bronchodilator testing shows whether airflow improves after inhaled medication. It helps separate COPD from asthma-like patterns and supports treatment planning.



























